MicroRNA 148a-3p promotes Thrombospondin-4 expression and enhances angiogenesis during tendinopathy development by...

Area of Science:

• Biomedical research
• Molecular biology
• Musculoskeletal disorders

Background:

• Tendinopathy is a common condition characterized by increased blood vessel formation (angiogenesis).
• The precise molecular mechanisms driving angiogenesis in tendinopathy are not fully understood.
• MicroRNAs (miRNAs) are emerging as key regulators in various biological processes, including angiogenesis.

Purpose of the Study:

• To investigate the role of miR-148a-3p in the development of angiogenesis in tendinopathy.
• To identify the molecular targets and pathways regulated by miR-148a-3p in tenocytes relevant to angiogenesis.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and immunohistochemical analysis were used to measure gene and protein expression levels.
• Bioinformatic analysis and luciferase reporter assays were employed to identify direct miRNA targets.
• Co-culture systems of tenocytes and endothelial cells (ECs) were utilized to assess the functional impact of miR-148a-3p on angiogenesis.

Main Results:

• miR-148a-3p expression was significantly elevated in tendinopathy tissues and correlated positively with CD34, an angiogenesis marker.
• Krüppel-like factor 6 (KLF6) was identified as a direct target of miR-148a-3p, with KLF6 expression being reduced in tendinopathy.
• miR-148a-3p promotes endothelial cell angiogenesis by targeting KLF6 and upregulating Thrombospondin-4 (Tsp-4) expression in tenocytes.

Conclusions:

• This study elucidates a novel molecular pathway where miR-148a-3p promotes tendinopathy-related angiogenesis.
• The miR-148a-3p/KLF6/Tsp-4 axis represents a potential therapeutic target for managing tendinopathy.
• Understanding this mechanism could pave the way for future treatments aimed at controlling aberrant angiogenesis in tendinopathy.